Modification of myocardial substrate use as a therapy for heart failure.
Despite advances in treatment, chronic heart failure is still associated with significant morbidity and a poor prognosis. The scope for further advances based on additional neurohumoral blockade is small. Effective adjunctive therapies acting via a different cellular mechanism would, therefore, be a...
Main Authors: | Abozguia, K, Clarke, K, Lee, L, Frenneaux, M |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2006
|
Similar Items
-
DYNAMIC CHANGES IN LEFT VENTRICULAR FUNCTION ON EXERCISE IN HEART FAILURE WITH PRESERVED EJECTION FRACTION: THE ROLE OF MYOCARDIAL ENERGY DEFICIENCY
by: Phan, T, et al.
Published: (2009) -
Myocardial substrate metabolism in heart disease.
by: Evans, R, et al.
Published: (2012) -
Impaired active relaxation during dynamic exercise in patients with heart failure with a preserved ejection fraction (HfpEF)
by: Phan, T, et al.
Published: (2008) -
Heart failure with preserved ejection fraction is characterized by dynamic impairment of active relaxation and contraction of the left ventricle on exercise and associated with myocardial energy deficiency.
by: Phan, T, et al.
Published: (2009) -
Metabolic manipulation in chronic heart failure: study protocol for a randomised controlled trial
by: Leon Francisco, et al.
Published: (2011-06-01)